IMPACT OF ANEMIA AND RIBAVIRIN DOSE REDUCTION ON SVR TO A TELAPREVIR-BASED REGIMEN IN PATIENTS WITH HCV GENOTYPE 1 AND PRIOR PEGINTERFERON/RIBAVIRIN TREATMENT FAILURE IN THE PHASE III REALIZE STUDY

被引:0
|
作者
Roberts, Stuart K. [1 ]
Andreone, Pietro [2 ]
Pol, Stanislas [3 ,4 ]
Younossi, Zobair M. [5 ,6 ]
Diago, Moises [7 ]
Lawitz, Eric [8 ]
Focaccia, Roberto [9 ]
Foster, Graham R. [10 ]
Horban, Andrzej [11 ]
Lonjon-Domanec, Isabelle [12 ]
DeMasi, Ralph [13 ]
van Heeswijk, Rolf [14 ]
Picchio, Gaston [13 ]
Witek, James [13 ]
Zeuzem, Stefan [15 ]
机构
[1] Alfred Hosp, Dept Gastroenterol, Melbourne, Vic, Australia
[2] Univ Bologna, Bologna, Italy
[3] Univ Paris 05, INSERM, U1016, Paris, France
[4] Cochin Hosp, Assistance Publ Hop Paris, Paris, France
[5] Inova Fairfax Hosp, Ctr Liver Dis, Falls Church, VA USA
[6] Inova Fairfax Hosp, Dept Med, Falls Church, VA USA
[7] Hosp Gen Valencia, Valencia, Spain
[8] Alamo Med Res, San Antonio, TX USA
[9] Emilio Ribas Infect Dis Inst, Sao Paulo, Brazil
[10] Queen Marys Univ London, Inst Cell & Mol Sci, London, England
[11] Med Univ Warsaw, Warsaw, Poland
[12] Janssen Pharmaceut, Paris, France
[13] Tibotec Inc, Titusville, NJ USA
[14] Tibotec BVBA, Beerse, Belgium
[15] Goethe Univ Frankfurt, Med Ctr, Frankfurt, Germany
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:1007A / 1008A
页数:2
相关论文
共 50 条
  • [1] EFFICACY AND SAFETY OF TELAPREVIR-BASED REGIMENS IN CIRRHOTIC PATIENTS WITH HCV GENOTYPE 1 AND PRIOR PEGINTERFERON/RIBAVIRIN TREATMENT FAILURE: SUBANALYSIS OF THE REALIZE PHASE III STUDY
    Pol, Stanislas
    Roberts, Stuart K.
    Andreone, Pietro
    Younossi, Zobair M.
    Diago, Moises
    Lawitz, Eric
    Focaccia, Roberto
    Foster, Graham R.
    Horban, Andrzej
    Lonjon-Domanec, Isabelle
    DeMasi, Ralph
    van Heeswijk, Rolf
    De Meyer, Sandra
    Picchio, Gaston
    Witek, James
    Zeuzem, Stefan
    HEPATOLOGY, 2011, 54 : 374A - 375A
  • [2] Efficacy and safety of telaprevir-based regimens in cirrhotic patients with HCV genotype 1 and prior peginterferon/ribavirin treatment failure: subanalysis of the REALIZE Phase III study
    Roberts, Stuart
    Pol, Stanislas
    Andreone, Pietro
    Younossi, Zobair
    Diago, Moises
    Lawitz, Eric J.
    Focaccia, Roberto
    Foster, Graham R.
    Horban, Andrzej
    Lonjon-Domanec, Isabelle
    Demasi, Ralph
    Heeswijk, Rolf V.
    Meyer, Sandra D.
    Picchio, Gaston
    Witek, James
    Zeuzem, Stefan
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 177 - 177
  • [3] Impact of insulin resistance on virologic response to a telaprevir-based regimen in patients with HCV genotype 1 and prior peginterferon/ribavirin treatment failure: post-hoc analysis of the REALIZE Phase III study
    Roberts, Stuart
    Younossi, Zobair
    Negro, Francesco
    Serfaty, Lawrence
    Pol, Stanislas
    Diago, Moises
    Zeuzem, Stefan
    Andreone, Pietro
    Lawitz, Eric J.
    Focaccia, Roberto
    Foster, Graham R.
    Horban, Andrzej
    Lonjon-Domanec, Isabelle
    Coate, Bruce
    Demasi, Ralph
    Picchio, Gaston
    Witek, James
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 178 - 179
  • [4] IMPACT OF INSULIN RESISTANCE ON VIROLOGIC RESPONSE TO A TELAPREVIR-BASED REGIMEN IN PATIENTS WITH HCV GENOTYPE 1 AND PRIOR PEGINTERFERON/RIBAVIRIN TREATMENT FAILURE: POST-HOC ANALYSIS OF THE REALIZE PHASE III STUDY
    Younossi, Zobair M.
    Negro, Francesco
    Serfaty, Lawrence
    Pol, Stanislas
    Diago, Moises
    Zeuzem, Stefan
    Andreone, Pietro
    Lawitz, Eric
    Roberts, Stuart K.
    Focaccia, Roberto
    Foster, Graham R.
    Horban, Andrzej
    Lonjon-Domanec, Isabelle
    Coate, Bruce
    DeMasi, Ralph
    Picchio, Gaston
    Witek, James
    HEPATOLOGY, 2011, 54 : 1008A - 1009A
  • [5] PREDICTORS OF VIROLOGIC RESPONSE WITH TELAPREVIR-BASED COMBINATION TREATMENT IN HCV GENOTYPE 1-INFECTED PATIENTS WITH PRIOR PEGINTERFERON/RIBAVIRIN TREATMENT FAILURE: POST-HOC ANALYSIS OF THE PHASE III REALIZE STUDY
    Berg, Thomas
    Andreone, Pietro
    Pol, Stanislas
    Roberts, Stuart K.
    Younossi, Zobair M.
    Diago, Moises
    Lawitz, Eric
    Focaccia, Roberto
    Foster, Graham R.
    Horban, Andrzej
    Lonjon-Domanec, Isabelle
    DeMasi, Ralph
    Picchio, Gaston
    Witek, James
    Zeuzem, Stefan
    HEPATOLOGY, 2011, 54 : 375A - 376A
  • [6] REALIZE TRIAL FINAL RESULTS: TELAPREVIR-BASED REGIMEN FOR GENOTYPE 1 HEPATITIS C VIRUS INFECTION IN PATIENTS WITH PRIOR NULL RESPONSE, PARTIAL RESPONSE OR RELAPSE TO PEGINTERFERON/RIBAVIRIN
    Zeuzem, S.
    Andreone, P.
    Pol, S.
    Lawitz, E. J.
    Diago, M.
    Roberts, S.
    Focaccia, R.
    Younossi, Z. M.
    Foster, G. R.
    Horban, A.
    Pockros, P. J.
    Van Heeswijk, R.
    de Meyer, S.
    Luo, D.
    Picchio, G.
    Beumont, M.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S3 - S3
  • [7] Telaprevir-Based Regimen in Genotype 1 Hepatitis C Virus-Infected Patients With Prior Null Response, Partial Response or Relapse to Peginterferon/Ribavirin: REALIZE Trial Final Results
    Pockros, Paul
    Zeuzem, Stefan
    Lawitz, Eric J.
    Younossi, Zobair M.
    Andreone, Pietro
    Pol, Stanislas
    Diago, Moises
    Roberts, Stuart K.
    Focaccia, Roberto
    Foster, Graham
    Horban, Andrzej
    van Heeswijk, Rolf
    De Meyer, Sandra
    Luo, Don
    Picchio, Gaston
    Beumont-Mauviel, Maria
    GASTROENTEROLOGY, 2011, 140 (05) : S898 - S898
  • [8] PRE-TREATMENT IP-10 LEVELS AND IL28B GENOTYPE IN PREDICTION OF SVR IN PRIOR TREATMENT-EXPERIENCED GENOTYPE 1 HCV PATIENTS TREATED WITH TELAPREVIR/PEGINTERFERON/ RIBAVIRIN IN THE REALIZE STUDY
    Vijgen, L.
    Talloen, W.
    Scholliers, A.
    Johansson, S.
    Tuefferd, M.
    De Meyer, S.
    Witek, J.
    Fanning, G.
    Picchio, G.
    Pol, S.
    Zeuzem, S.
    Aerssens, J.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S462 - S462
  • [9] Telaprevir with peginterferon and ribavirin for treatment-naive patients chronically infected with HCV of genotype 1 in Japan
    Kumada, Hiromitsu
    Toyota, Joji
    Okanoue, Takeshi
    Chayama, Kazuaki
    Tsubouchi, Hirohito
    Hayashi, Norio
    JOURNAL OF HEPATOLOGY, 2012, 56 (01) : 78 - 84
  • [10] Telaprevir-based therapy in G1 HCV-infected patients with prior null response, partial response or relapse to peginterferon/ribavirin: REALIZE trial final results
    Mullhaupt, Beat
    Zeuzem, Stefan
    Andreone, Pietro
    Pol, Stanislas
    Lawitz, Eric
    Diago, Moises
    Roberts, S.
    Focaccia, Roberto
    Younossi, Zobair
    Foster, Graham
    Horban, Andrzej
    Pockros, Paul. J.
    Van Heeswijk, Rolf
    de Meyer, Sandra
    Luo, Donghan
    Picchio, Gaston
    Beumont, Maria
    SWISS MEDICAL WEEKLY, 2011, 141 : 6S - 6S